Related Experiment Video
Updated: Apr 1, 2026

Characterization of MLKL-mediated Plasma Membrane Rupture in Necroptosis
Published on: August 7, 2018
Identification of a novel compound that inhibits both mitochondria-mediated necrosis and apoptosis
Satoko Arakawa1, Ikuko Nakanomyo1, Yoko Kudo-Sakamoto2
1Department of Pathological Cell Biology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo, 113-8510, Japan.
Abstract:
In various pathological events, particularly in oxygen radical-mediated cell injury, both apoptosis and necrosis play essential roles. Apoptosis and some types of necrosis are induced via increases in mitochondrial membrane permeability, called mitochondrial outer membrane permeabilization (MOMP) and permeability transition pore (PTP) opening, respectively. To search for small compounds that inhibit both MOMP-mediated apoptosis and PTP-mediated necrosis, we performed a mitochondria-based high-throughput screening of a chemical library. We identified TMD#7538, a small compound that inhibits both MOMP and PTP opening. Consistent with the fact that this compound inhibited both apoptosis and necrosis, it efficiently suppressed H2O2-induced cell death in mouse embryonic fibroblasts and rat neonatal cardiomyocytes.
Insights
Researchers screened for compounds inhibiting both apoptosis and necrosis. They found TMD#7538, which blocks mitochondrial outer membrane permeabilization (MOMP) and permeability transition pore (PTP) opening, suppressing cell death.
Area of Science:
- Biochemistry
- Cell Biology
- Pharmacology
Background:
- Pathological cell death, including apoptosis and necrosis, is crucial in various diseases.
- Mitochondrial outer membrane permeabilization (MOMP) and permeability transition pore (PTP) opening are key mechanisms inducing these cell death pathways.
- Oxygen radical-mediated cell injury often involves these mitochondrial events.
Purpose of the Study:
- To identify small compounds capable of inhibiting both MOMP-mediated apoptosis and PTP-mediated necrosis.
- To find novel therapeutic agents for pathological conditions involving cell death.
Main Methods:
- Mitochondria-based high-throughput screening of a chemical library.
- Assay development to detect MOMP and PTP opening.
- Cell death assays using H2O2-induced injury in mouse embryonic fibroblasts and rat neonatal cardiomyocytes.
Main Results:
- A novel small compound, TMD#7538, was identified.
- TMD#7538 effectively inhibits both MOMP and PTP opening.
- TMD#7538 suppressed H2O2-induced apoptosis and necrosis in tested cell types.
Conclusions:
- TMD#7538 is a potent inhibitor of key mitochondrial cell death pathways.
- This compound demonstrates potential therapeutic value in mitigating cell injury associated with apoptosis and necrosis.
- Targeting mitochondrial membrane permeability offers a promising strategy for treating oxidative stress-related pathologies.
More Related Videos
19:44Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
Published on: May 30, 2012
13:20Detection of Mitochondria Membrane Potential to Study CLIC4 Knockdown-induced HN4 Cell Apoptosis In Vitro
Published on: July 17, 2018
Related Concept Videos
Necrosis
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Apoptosis
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...